Scientific Program
10th International Congress on Psychopharmacology
Shortcuts
...
10:00 - 12:00
COURSE 1
Attention-Deficit/ Hyperactivity Disorder (ADHD)
Murat ALTIN (TAP)
13:30 - 15:00
CONFERENCE 1
Chairperson/Moderator:
Feyza ARICIOĞLU (TAP)
Antiinflammatory treatments in schizophrenia and bipolar disorder
Dost ÖNGÜR (USA)
15:30 - 17:00
SYMPOSIA ORAL SESSION 5
Recent technologigal developments such as neuroimaging, machine learning and pharmacogenetics innovations in psychiatry
Recent technologigal developments such as neuroimaging, machine learning and pharmacogenetics innovations in psychiatry
Chairperson/Moderator:
Marek KUBICKI (USA), Andrew GREENSHAW (Canada)
Patterns of gray matter abnormalities in patients with first-episode and treatment-naive schizophrenia
Mingli LI (China)
Neuroimaing and machine learning in schizophrenia
Sugai LIANG (China)
Pharmacogenetics applications in psychiatric practice
Tao LI (China)
White matter: new therapeutic target for depression
Xin Min LI (Canada)
17:30 - 19:00
OPENING LECTURE
Chairperson/Moderator:
Serdar DURSUN (Canada)
Innovations in Neuropsychiatry: New Approaches to Old Problems
Leslie CITROME (USA)
19:00 - 20:30
ORAL PRESENTATIONS
SS-001, SS-003, SS-004, SS-005, SS-008, SS-011, SS-032, SS-119
SS-001, SS-003, SS-004, SS-005, SS-008, SS-011, SS-032, SS-119
Chairperson/Moderator:
Murat ALTIN (TAP)
10:00 - 12:00
COURSE 2
Challenges in Bipolar Depression Treatment
Adnan ÖZÇETİN
13:30 - 15:00
SYMPOSIA ORAL SESSION 1
Organicity in Psychiatric Disorders
Organicity in Psychiatric Disorders
Chairperson/Moderator:
Mecit ÇALIŞKAN, Murat DEMET
Psychiatry at the crossroads of psychological or organic
Mecit ÇALIŞKAN
Organic disorders with psychiatric manifestations
Servet EBRİNÇ
Effects of psychological trauma on disorders with organic etiologies
Fulya GÖK
Psychotherapy approaches in organic disorders
Anıl GÜNDÜZ
15:30 - 17:00
COURSE 5
Use of metaphors in cognitive behavioral therapy in children and adolescents
Vahdet GÖRMEZ (TAP)
19:00 - 20:30
ORAL PRESENTATIONS
SS-007, SS-009, SS-010, SS-012, SS-013, SS-014, SS-015, SS-016, SS-036, SS-138
SS-007, SS-009, SS-010, SS-012, SS-013, SS-014, SS-015, SS-016, SS-036, SS-138
Chairperson/Moderator:
Ömer YANARTAŞ (TAP)
10:00 - 12:00
COURSE 3
Acceptance and Commitment Therapy (ACT)
Hasan Turan KARATEPE (TAP),Merve TERZİOĞLU,Furkan Bahadır ALPTEKİN
13:30 - 15:00
SYMPOSIA ORAL SESSION 2
From Manic Depressive Psychosis to Bipolar Disorders
From Manic Depressive Psychosis to Bipolar Disorders
Chairperson/Moderator:
Musa TOSUN, Vesile ALTINYAZAR
History of bipolar disorder
Musa TOSUN
Mania induced by antidepressants
Ömer Faruk DEMİREL
Mania in elderly
Burç Çağrı POYRAZ
Bipolar disorder and anxiety comorbidity
Cana AKSOY POYRAZ
Mania due to general medical conditions
Şenol TURAN
15:30 - 17:00
WORKSHOP 6
The Subtleties of Scientific Publishing and Hidden Traps
The Subtleties of Scientific Publishing and Hidden Traps
Scientific publishing: current status and Web of Science policy
Mila CAHUE (Web of Science Europe Editor)
Ins and outs of academic publishing: frequent mistakes and ins and outs of fast and qualitative publishing
Metin TUNC (Thomson Reuters Former Representative)
19:00 - 20:30
ORAL PRESENTATIONS
SS-017, SS-018, SS-019, SS-020, SS-021, SS-022, SS-023, SS-024, SS-133, SS-135
SS-017, SS-018, SS-019, SS-020, SS-021, SS-022, SS-023, SS-024, SS-133, SS-135
Chairperson/Moderator:
Mesut YILDIZ (TAP)
10:00 - 12:00
WORKSHOP 1
Outpatient Approaches in Demential Diagnosis and Treatment
Işın BARAL KULAKSIZOĞLU
13:30 - 15:00
SYMPOSIA ORAL SESSION 3
Leptin and Ghrelin in Psychiatric Disorders
Leptin and Ghrelin in Psychiatric Disorders
Chairperson/Moderator:
Özlem ÖZEL ÖZCAN, Kemal Utku YAZICI
Leptin,ghrelin, and other peptide hormones: an overview of their structures and functions
Halil KARA
Leptin and mood disorders
S. Burak AÇIKEL
Leptin, ghrelin, and ADHD
Ümit IŞIK
Leptin and anxiety disorders
Necati UZUN
15:30 - 17:00
COURSE 6
Chairperson/Moderator:
Murat DEMET
Loss of efficacy in antidepressant and antipsychotic medication treatments, resistance development, and coping strategies
Vesile ALTINYAZAR, Murat DEMET
19:00 - 20:30
ORAL PRESENTATIONS
SS-025, SS-026, SS-027, SS-028, SS-029, SS-030, SS-031, SS-033, SS-034, SS-035
SS-025, SS-026, SS-027, SS-028, SS-029, SS-030, SS-031, SS-033, SS-034, SS-035
Chairperson/Moderator:
Vahdet GÖRMEZ (TAP)
10:00 - 12:00
COURSE 4
Approaches to the Military Personnel with Psychiatric Problems
Özgür MADEN
13:30 - 15:00
SYMPOSIA ORAL SESSION 4
Practical Ways of Cognitive Assessment in Schizophrenia Patients
Practical Ways of Cognitive Assessment in Schizophrenia Patients
Chairperson/Moderator:
Adnan ÖZÇETİN, Murat ALTIN (TAP)
A new model for assessment of cognitive functions in patients with schizophrenia (BDG-TR): theoretical background
Şükriye BOŞGELMEZ
Cognitive assessment interview in schizophrenia patients: practical applications
Esra YAZICI
A new outlook, a practical solution in assessment of cognitive functions in patients with schizophrenia
Mustafa YILDIZ
15:30 - 17:00
COURSE 7
Principles of psychiatric healing
Mustafa YILDIZ (TAP)
19:00 - 20:30
ORAL PRESENTATIONS
SS-037, SS-039, SS-040, SS-041, SS-042, SS-045, SS-082, SS-092
SS-037, SS-039, SS-040, SS-041, SS-042, SS-045, SS-082, SS-092
Chairperson/Moderator:
Umut Mert AKSOY (TAP)
07:00 - 08:30
COURSE 9
Transformative Effect of Neuroscience on Psychotherapies
Melike NEBİOĞLU (TAP)
09:00 - 10:30
WORKSHOP 3
Chairperson/Moderator:
Yasemen IŞIK, Ali Evren TUFAN (TAP)
Psychoeducation in ADHD and other psychiatric disorders in children and adolescents
Maite FERRIN (UK)
11:00 - 12:00
SATELLITE SYMPOSIUM
A new solution in schizophrenia treatment: TREVICTA
A new solution in schizophrenia treatment: TREVICTA
Long-acting atypical antipsychotics in schizophrenia treatment
Özcan UZUN
Three-month paliperidone palmitate treatment in schizophrenia treatment
Elif Anıl YAĞCIOĞLU
13:00 - 14:30
DEBATE
Chairperson/Moderator:
Leslie CITROME (USA), Xin Min LI (Canada)
Antidepressant treatment for bipolar depression: continue to after remission?
PROS: Dost ÖNGÜR (USA), CONS: Serdar DURSUN (Canada)
15:00 - 16:30
SYMPOSIA ORAL SESSION 8
Artificial Intelligence in Psychiatry: Implications for Diagnostics and Prognostics
Artificial Intelligence in Psychiatry: Implications for Diagnostics and Prognostics
Chairperson/Moderator:
Andrew GREENSHAW (Canada), Serdar DURSUN (Canada)
Artificial intelligence in psychiatry: implications for diagnostics and prognostics
Andrew GREENSHAW (Canada)
Machine learning applications in high risk groups: are we able to predict who will develop schizophrenia?
Ezgi İNCE GULIYEV
Audio-visual features in bipolar disorders
Elvan ÇİFTÇİ
17:00 - 18:30
CONFERENCE 5
Chairperson/Moderator:
Kemal SAYAR (TAP)
Psychopharmacology of Aggression and Violence
Leslie CITROME (USA)
20:00 - 21:30
COURSE 11
EMDR Course
Alişan Burak YAŞAR
07:00 - 08:30
WORKSHOP 2
Stigmatization in Bipolar Disorders
Rukiye AY
09:00 - 10:30
CONFERENCE 2
Chairperson/Moderator:
Kazım YAZICI (TAP)
Thinking about auditory verbal hallucinations: the relationship of psychopathology and nosology
Femi OYEBODE (UK)
13:00 - 14:30
CONFERENCE 3
Chairperson/Moderator:
Yankı YAZGAN, Saliha BAYKAL
Applying cultural formulation to child psychiatry cases
Jaswant GUZDER (Canada)
15:00 - 16:30
CONFERENCE 4
Chairperson/Moderator:
Jeffrey NEWCORN (USA), Bengi SEMERCİ (TAP)
Neurobiology of ADHD across the Life cycle
Joseph BIEDERMAN (USA)
17:00 - 18:30
SYMPOSIA ORAL SESSION 11
Attention-Deficit/ Hyperactivity Disorder (ADHD): From Diagnosis to Treatment
Attention-Deficit/ Hyperactivity Disorder (ADHD): From Diagnosis to Treatment
Chairperson/Moderator:
Vahdet GÖRMEZ (TAP), Mecit ÇALIŞKAN
ADHD diagnosis: DIVA (Diagnostic Interview for ADHD in adults) and other diagnostic tools
Arif ÇİPİL
ADHD treatment and recent updates
Sencan SERTÇELİK
ADHD neurobiology and recent studies
Gökçe Elif SARIDOĞAN
ADHD and childhood traumas
Alişan Burak YAŞAR
20:00 - 21:30
COURSE 12
Crisis İntervention program for children and adolescents [CIPCA] to prevent posttraumatic psychopathology: a brief overview
Veysi ÇERİ (TAP), Serhat NASIROĞLU (TAP)
07:00 - 08:30
COURSE 10
Comparative Forensic Psychiatry: Mental Health Law in Turkey
Comparative Forensic Psychiatry: Mental Health Law in Turkey
Expert witnessing and current forensic psychiatry practices: update on mental health law in Turkey
Mustafa SOLMAZ (TAP)
Involuntary/compulsive treatment, and forensic order: comparison between UK and Turkish systems
Yasin Hasan BALCIOĞLU (TAP)
09:00 - 10:30
SYMPOSIA ORAL SESSION 6
Biological Markers of Suicide and Self-Harming Behavior in Children and Adolescents
Biological Markers of Suicide and Self-Harming Behavior in Children and Adolescents
Chairperson/Moderator:
Mücahit ÖZTÜRK (TAP), Hatice AKSU
Suicide, self-harming behavior and neuropeptides
Ayhan BİLGİÇ
Suicide, self- harming behavior and neurohormones
Ömer Faruk AKÇA
Suicide, self-harming behavior and genetics
Nagihan ŞADAY DUMAN
Suicide, self-harming behavior, and immunology
Merve SERTDEMİR
13:00 - 14:30
WORKSHOP 4
Chairperson/Moderator:
Işık GÖRKER, Özden ÜNERİ
Assessment and Management of Children and Adolescents with Severe and Complex Treatment-Resistant Neuropsychiatric Disorders
Paramala SANTOSH (UK)
Clinical features and pharmacological management process of a 10 years-old male child diagnosed with autism spectrum disorder and treatment resistant self-harming behaviors
Hasan Cem AYKUTLU
Treatment resistant compulsive touching behavior and sensory hypersensitivity in a case with Hamamy Syndrome
Tuba MUTLUER (TAP)
Management of challenging behaviors of a young adult with autism spectrum disorder
Özge KILIÇ
15:00 - 16:30
SYMPOSIA ORAL SESSION 9
Being a Child, Woman or Parent? What Does the Brain Tell Us?
Being a Child, Woman or Parent? What Does the Brain Tell Us?
Chairperson/Moderator:
Mustafa YILDIZ (TAP), Atila EROL
Woman's brain vs. man's brain: how similar, how different?
Esra YAZICI
Does motherhood affect the mother's brain?
Gökşen YÜKSEL
Is father's brain different?
Gökhan ÖZPOLAT
What happens in a child's brain while interacting with parents?
Zehra TOPAL
17:00 - 18:30
SYMPOSIA ORAL SESSION 12
Neurodevelopmental Disorders in Child Psychiatry
Neurodevelopmental Disorders in Child Psychiatry
Chairperson/Moderator:
Koray KARABEKİROĞLU, İpek PERÇİNEL YAZICI
Evaluation of disruptive behaviors at school within the context of complex neurodevelopmental disorders
Yankı YAZGAN
Immunological and neurological markers of developmental disorders
Burak DOĞANGÜN
Complementary and alternative treatments in ASD
Nihal YURTERİ
Genetic evaluation in defining the etiology of autism spectrum disorder
Işık GÖRKER
20:00 - 21:30
COURSE 13
Introduction to psychodrama applications in children and adolescents
Özden ÜNERİ
07:00 - 08:30
ORAL PRESENTATIONS 6
SS-044, SS-047, SS-048, SS-049, SS-050, SS-051, SS-065, SS-085, SS-098
SS-044, SS-047, SS-048, SS-049, SS-050, SS-051, SS-065, SS-085, SS-098
Chairperson/Moderator:
Mesut YILDIZ (TAP)
09:00 - 10:30
SYMPOSIA ORAL SESSION 7
Coming Back to Life While Touching theTrauma: Trauma and Associated Processes from ACT Perspective
Coming Back to Life While Touching theTrauma: Trauma and Associated Processes from ACT Perspective
Chairperson/Moderator:
K. Fatih YAVUZ (TAP), Hasan Turan KARATEPE (TAP)
Solution zone intertwined with the problem: narrative nature of trauma
Hasan Turan KARATEPE (TAP)
Here and now with the trauma: self-awareness based approaches
Mehmet Emrah KARADERE
Seizing the life while avoiding the pain of trauma: acceptance-based exposure from the perspective of the ACT
Şengül İLKAY
Taking care of our pain with compassion: ACT-based self-compassion approaches to trauma associated with guilt and shame
Sevinç ULUSOY
13:00 - 14:30
ORAL PRESENTATIONS 9
SS-073, SS-074, SS-077, SS-078, SS-079, SS-080, SS-081, SS-083, SS-084
SS-073, SS-074, SS-077, SS-078, SS-079, SS-080, SS-081, SS-083, SS-084
Chairperson/Moderator:
Mesut YILDIZ (TAP), Ömer YANARTAŞ (TAP)
15:00 - 16:30
SYMPOSIA ORAL SESSION 10
Recent Advances in Biomarkers for Psychiatric Disorders
Recent Advances in Biomarkers for Psychiatric Disorders
Chairperson/Moderator:
Çiçek HOCAOĞLU, Feyza ARICIOĞLU (TAP)
Biomarkers in anxiety disorders: recent updates
Memduha AYDIN
Biomarkers in schizophrenia: recent updates
Meltem PUŞUROĞLU
Biomarkers in mood disorders: recent updates
Fatmagül HELVACI ÇELİK
The role of biomarkers in dementia diagnosis and treatment: recent updates
Esra YANCAR DEMİR
17:00 - 18:30
SYMPOSIA ORAL SESSION 13
Psychopharmacological Approaches in Preschool Children
Psychopharmacological Approaches in Preschool Children
Chairperson/Moderator:
Mücahit ÖZTÜRK (TAP), Tülin FİDAN
ADHD and tic disorders in preschool
Özlem YILDIZ
Obsessive-compulsive disorder (OCD) in preschool
Nursu ÇAKIN MEMİK
Treatment of mood disorders in preschool-age children
Özden ÜNERİ
Developmental disorders and mental retardation in preschool
Şaziye Senem BAŞGÜL (TAP)
20:00 - 21:30
COURSE 14
Cognitive Behavioral Therapy Approach to Adult ADHD from the CBT Work Group
Cognitive Behavioral Therapy Approach to Adult ADHD from the CBT Work Group
Classical CBT
Gülay OĞUZ
Mindfulness therapy
Gülçin ŞENYUVA
Metacognitive therapy
Mükerrem GÜVEN
07:00 - 08:30
ORAL PRESENTATIONS 7
SS-052, SS-058, SS-059, SS-060, SS-061, SS-121
SS-052, SS-058, SS-059, SS-060, SS-061, SS-121
Chairperson/Moderator:
Ömer YANARTAS (TAP)
09:00 - 10:30
ORAL PRESENTATIONS 8
SS-062, SS-063, SS-066, SS-067, SS-069, SS-070, SS-071, SS-072, SS-075
SS-062, SS-063, SS-066, SS-067, SS-069, SS-070, SS-071, SS-072, SS-075
Chairperson/Moderator:
Mesut YILDIZ (TAP), Ömer YANARTAŞ (TAP)
20:00 - 21:30
WORKSHOP 5
Management of behavioral problems in intellectually disabled adults using case examples
Aynur GÖRMEZ (TAP)
07:00 - 08:30
COURSE 15
Having been traumatized or not while treating trauma
Sevinç ULUSOY,Şengül İLKAY ,Zülal ÇELİK
09:00 - 10:30
CONFERENCE 6
Chairperson/Moderator:
David OSSER (USA)
Lithium in the 21st century
Allan YOUNG (UK)
11:00 - 12:30
SYMPOSIA ORAL SESSION 18
Psychiatry and Psychotherapy: Quo Vadis?
Psychiatry and Psychotherapy: Quo Vadis?
Chairperson/Moderator:
Erol GÖKA (TAP), Serhat ÇITAK (TAP)
What does biological psychiatry tell us?
Kazım YAZICI
Does psychotherapy have a future?
Hakan TÜRKÇAPAR
Postpsychiatry: searching for new paradigms in psychiatry
Kemal SAYAR (TAP)
13:30 - 15:00
JOINT CONFERENCE 1
Chairperson/Moderator:
Dost ÖNGÜR (USA)
Latest algorhythm on major depression and managing the side effects of lithium
David OSSER (USA)
Evidence based treatment of Mania in clinical practic
Allan YOUNG (UK)
15:30 - 17:00
CONFERENCE 10
Psychiatry, Psychoterapy and Art
Psychiatry, Psychoterapy and Art
Chairperson/Moderator:
İhsan KARAMAN
Psychiatry and poetry
Femi OYEBODE (UK)
Psychotherapy and painting
Jaswant GUZDER (Canada)
Therapy with poetry
Kemal SAYAR (TAP)
17:30 - 19:00
CONFERENCE 11
Chairperson/Moderator:
Serdar DURSUN (Canada)
Latest update of the algorithm for schizophrenia from the Psychopharmacology Algorithm Project at the Harvard South Shore Program
David OSSER (USA)
20:00 - 22:00
Discussing refugee traumas through the documentary ''And Still We Review''
Chairperson/Moderator:
Kemal SAYAR (TAP), Bengi SEMERCİ (TAP)
Farhad EİVAZİ (Director)
07:00 - 08:30
COURSE 16
SPSS for dummies
Yüksel KIVRAK
09:00 - 10:30
SYMPOSIA ORAL SESSION 14
Migrating Mind and Impact of Immigration on Mental Health
Migrating Mind and Impact of Immigration on Mental Health
Chairperson/Moderator:
Bengi SEMERCİ (TAP), Didem ÖZTOP
Development of school-based prevention programs for refugee children
Vahdet GÖRMEZ (TAP)
Therapeutic approach in post-traumatic stress disorder (PTSD)
Serhat NASIROĞLU (TAP)
Normalization of abnormality: revisiting adverse childhood experiences from a developmental perspective
Veysi ÇERİ (TAP)
Migration: impact on children's mental health
Bengi SEMERCİ (TAP)
11:00 - 12:30
SYMPOSIA ORAL SESSION 19
Cannabis: 360-Degree Review
Cannabis: 360-Degree Review
Chairperson/Moderator:
Andrew GREENSHAW (Canada), Hakan COŞKUNOL
Is Cannabis a potential neurotoxin in the developing brain?
Serdar DURSUN (Canada)
Is Cannabis a potential psychotropic medication in psychiatry?
Dost ÖNGÜR (USA)
What is the future of Cannabis in Medicine and Society?
Andrew GREENSHAW (Canada)
Are we swapping tobacco for cannabis? Implications for psychiatry
Kültegin ÖGEL
13:30 - 15:00
CONFERENCE 8
Chairperson/Moderator:
Birim GÜNAY KILIÇ, Şaziye Senem BAŞGÜL
Use of technology for assessment and management of common child and adolescent neurodevelopmental disorders
Paramala SANTOSH (UK)
15:30 - 17:00
SYMPOSIA ORAL SESSION 23
Towards an Anti-Drug Vaccine
Towards an Anti-Drug Vaccine
Chairperson/Moderator:
Hakan COŞKUNOL, Kültegin ÖGEL
Aptamers, recombinant proteins and immunization studies for drug addiction
Serap EVREN
Naturalization studies for on-site saliva diagnostic kits for the detection of drug addiction
Suna TİMUR
What should be our national targets for anti-drug vaccine studies at the Ege University School of Medicine's Department of Psychiatry
Hakan COŞKUNOL
17:30 - 19:00
SYMPOSIA ORAL SESSION 26
From Neurobiology to Treatment in Drug Addiction: An Update
From Neurobiology to Treatment in Drug Addiction: An Update
Chairperson/Moderator:
Kültegin ÖGEL, Hakan COŞKUNOL
Neurobiology of drug addiction
Cavid GULIYEV
Neurobiology of CBT in drug addiction therapies
Kinyas TEKİN
Neurobiology of mindfullness therapies in drug addiction
Zehra Olcay TUNA
Approach to the children of addicted parents: From neurobiology to clinical practice
Burcu OĞUZDOĞAN
07:00 - 08:30
CASE DISCUSSION
Electroconvulsive therapy (ECT) applications in children and adolescents
Şaziye Senem BAŞGÜL (TAP)
09:00 - 10:30
SYMPOSIA ORAL SESSION 15
Quantitative EEG Findings in Psychopharmacological Treatment of ADHD: Possible Markers and Their Relationships with Symptoms, Motor Competence, Cognitive Skills and Treatment Response
Quantitative EEG Findings in Psychopharmacological Treatment of ADHD: Possible Markers and Their Relationships with Symptoms, Motor Competence, Cognitive Skills and Treatment Response
Chairperson/Moderator:
Özlem ÖZEL ÖZCAN, Ali Evren TUFAN
Quantitative EEG findings in psychopharmacological treatment of ADHD: study protocol
Ebru ÇENGEL KÜLTÜR
Delta, theta, alpha, beta, and gamma response oscillations in school-age children with attention-deficit/ hyperactivity disorder
Nurhan ERBİL
EEG signatures of attention deficit/ hyperactivity disorder: clinical correlations
Halime Tuna ÇAK ESEN
Effects of methylphenidate on EEG characteristics in school-age children with attention-deficit/ hyperactivity disorder
Yusuf KARAER
EEG characteristics of responders and non-responders to medium-term treatment with atomoxetine in school-age children with attention-deficit/ hyperactivity disorder
Abdulbaki ARTIK
11:00 - 12:30
CONFERENCE 7
Chairperson/Moderator:
Ayşe ARMAN, Ebru ÇENGEL KÜLTÜR
How do drugs for ADHD work? Neuropharmacology and the brain
Jeffrey NEWCORN (USA)
13:30 - 15:00
CONFERENCE 9
Chairperson/Moderator:
Rüstem AŞKIN, Xin Min LI (Canada)
The digital revolution in mental health: APEC digital hub for best practices in mental health
Andrew GREENSHAW (Canada)
15:30 - 17:00
SYMPOSIA ORAL SESSION 24
Comorbidity in ADHD: A Psychopharmacological Perspective
Comorbidity in ADHD: A Psychopharmacological Perspective
Chairperson/Moderator:
Özlem YILDIZ, Ali Evren TUFAN (TAP)
Effects of ADHD regarding self-concept on quality of life
Ayşe ARMAN
ADHD and forensics
Wolfgang RETZ (Germany)
Differential diagnosis and treatment of ADHD and bipolar Disorder
Yasemen IŞIK
Treatment of ADHD symptoms comorbid with ASD and the effect of treatment on ASD symptoms in general
Atilla CERANOĞLU (USA)
17:30 - 19:00
COURSE 18
Adult ADHD: Impacts on Careers and Marriage and Proposed Solutions
Adult ADHD: Impacts on Careers and Marriage and Proposed Solutions
Arzu Erkan YÜCE,Bengi SEMERCİ (TAP)
07:00 - 08:30
COURSE 17
Anticholinergic medications in psychiatry: the good, the bad and the ugly
Mehmet İlkin NAHARCI,İlker TAŞÇI
09:00 - 10:30
SYMPOSIA ORAL SESSION 16
Virtual or Real? A New Technology and Its Promises in Clinical Practice
Virtual or Real? A New Technology and Its Promises in Clinical Practice
Chairperson/Moderator:
Köksal ALPTEKİN, K. Fatih YAVUZ (TAP)
Virtual reality (VR): A general framework and principles
Furkan Bahadır ALPTEKİN
What does virtual reality (VR) promise in psychiatry?
Merve TERZİOĞLU
Use of virtual reality (VR) in psychiatric practice
Şengül İLKAY
Clinical applications of the use of virtual reality (VR)
Hüseyin Şehit BURHAN
11:00 - 12:30
SYMPOSIA ORAL SESSION 20
Lesser-Known Topics in Eating Disorders
Lesser-Known Topics in Eating Disorders
Chairperson/Moderator:
Çiçek HOCAOĞLU, Atila EROL
Orthorexia nervosa: diagnosis and treatment approaches
Çiçek HOCAOĞLU
Bigorexia: diagnosis and treatment approaches
Çağdaş Hünkar YELOĞLU
Avoidant/ restrictive food intake disorder (ARFID): diagnosis and treatment approaches
Emrah KARADERE
Pica/ rumination disorder: diagnosis and treatment approaches
Murat KAÇAR
13:30 - 15:00
SYMPOSIA ORAL SESSION 21
Myths and Realities in Substance Dependence
Myths and Realities in Substance Dependence
Chairperson/Moderator:
Hakan COŞKUNOL, Kültegin ÖGEL
Myths and realities in substance withdrawal
Ahmet Bülent YAZICI
Myths and realities in substance dependence during perinatal period
Esra YAZICI
Is food addiction a myth or a reality?
Atila EROL
Myths and realities in substance dependence during adolescence
Gresa ÇARKAXHIU BULUT
15:30 - 17:00
SYMPOSIA ORAL SESSION 25
New Approaches in Adult Attention-Deficit/ Hyperactivity Disorder (ADHD)
New Approaches in Adult Attention-Deficit/ Hyperactivity Disorder (ADHD)
Chairperson/Moderator:
Umut Mert AKSOY (TAP)
Interview tools and imaging modalities in adult ADHD
Murat ALTIN (TAP)
EEG changes in ADHD and EEG as a diagnostic tool
Figen YAVLAL
Computer-based tests in ADHD diagnosis
Ferda KORKMAZ ÖZKANOĞLU
17:30 - 19:00
SYMPOSIA ORAL SESSION 27
Novel Topics and Approaches in Child and Adolescent Psychiatry
Novel Topics and Approaches in Child and Adolescent Psychiatry
Chairperson/Moderator:
Koray KARABEKİROĞLU, Burak DOĞANGÜN
Cognitive behavioral therapy [CBT] approaches in anxious children and inclusion of families in treatment
Hatice AKSU
Off label use of atypical antipsychotic drugs in pediatric population: a double-edged sword
Çiğdem YEKTAŞ
Gender identity disorder or gender dysphoria: management according to child and adolescent psychiatry
Birim GÜNAY KILIÇ
Atypical olfaction pattern in autism: a possible first clue in early diagnosis
Mahmut ÇAKIR
07:00 - 08:30
ORAL PRESENTATIONS 10
SS-086, SS-087, SS-088, SS-091, SS-095, SS-096, SS-097, SS-100, SS-139, SS-141
SS-086, SS-087, SS-088, SS-091, SS-095, SS-096, SS-097, SS-100, SS-139, SS-141
Chairperson/Moderator:
Murat ALTIN (TAP), Ömer YANARTAŞ (TAP)
09:00 - 10:30
SYMPOSIA ORAL SESSION 17
Current Psychotherapy Approaches in Depression Treatment
Current Psychotherapy Approaches in Depression Treatment
Chairperson/Moderator:
Serhat ÇITAK (TAP), Hakan TÜRKÇAPAR (TAP)
Willingness to accept the value of sadness: ACT applications for depressive spectrum disorders
Hasan Turan KARATEPE (TAP)
Current CBT approaches in depression treatment
Kadir ÖZDEL
Psychodynamic psychotherapy in depression treatment within the framework of current developments
Serhat ÇITAK (TAP)
11:00 - 12:30
ORAL PRESENTATIONS 11
SS-094, SS-099, SS-101, SS-102, SS-104, SS-113, SS-118, SS-125, SS-134
SS-094, SS-099, SS-101, SS-102, SS-104, SS-113, SS-118, SS-125, SS-134
Chairperson/Moderator:
Murat ALTIN (TAP), Ömer YANARTAŞ (TAP)
13:30 - 15:00
SYMPOSIA ORAL SESSION 22
Sound Disorders
Sound Disorders
Chairperson/Moderator:
Hasan Turan KARATEPE (TAP), Mesut YILDIZ (TAP)
Stuttering and stuttering therapy
Gamze YEŞİLLİ
Functional sound disorders and psychogenic dysphonia
Emel Çadallı TATAR
Puberphonia (mutational falsetto or functional falsetto)
Necati ENVER
17:30 - 19:00
CONFERENCE 12
Chairperson/Moderator:
Serhat ÇITAK (TAP)
Erectile dysfunction from all aspects
Ihsan KARAMAN
07:00 - 08:30
COURSE 19
Virtual Reality (VR): applications through acceptance and commitment therapy (ACT)
Furkan Bahadır ALPTEKİN,Hüseyin Şehit BURHAN
09:00 - 10:30
JOINT CONFERENCE 2
Insights from Basic and Clinical Research: Treatment Resistance Depression (TRD)
Insights from Basic and Clinical Research: Treatment Resistance Depression (TRD)
Chairperson/Moderator:
David OSSER (USA), Serhat ÇITAK (TAP)
Neurobiological basis of TRD: current status and future projections
Feyza ARICIOĞLU (TAP)
Rapid effectiveness of intravenous ketamine for ultraresistant depression in a clinical setting and evidence for baseline anhedonia as a clinical predictor of effectiveness
Serdar DURSUN (Canada)
11:00 - 12:30
CONFERENCE 14
Chairperson/Moderator:
Kemal SAYAR (TAP)
Psychopathology and cognitive neuroscience- the example of delusional misidentification syndromes
Femi OYEBODE (UK)
13:30 - 15:00
CONFERENCE 16
Chairperson/Moderator:
Birim GÜNAY KILIÇ, Didem ÖZTOP
Intervention in early onset psychosis
Maite FERRIN (UK)
15:30 - 17:00
JOINT CONFERENCE 3
Neuroimaging Studies in Psychiatry: An Update
Neuroimaging Studies in Psychiatry: An Update
Chairperson/Moderator:
Xin Min LI (Canada)
Neuroimaging evidence for white matter pathology across schizophrenia course and its terapeutic implications
Marek KUBICKI (USA)
How do sexual traumas make changes in the brains of adolescents?
Ali Saffet GÖNÜL (TAP)
17:30 - 19:00
SYMPOSIA ORAL SESSION 39
Rational Versus Irrational Drug Use
Rational Versus Irrational Drug Use
Chairperson/Moderator:
Rüstem AŞKIN, Bengi SEMERCİ (TAP)
Economical costs
Mesil AKSOY (TR Ministry of Health, Director of Rational Drug Use Department)
Educating primary care physicians in rational drug use
Rüstem AŞKIN
Serious consequences of drug-drug interactions
Mesut ÇETİN (TAP)
07:00 - 08:30
COURSE 20
Diagnostic challenges, instruments used and pharmacological treatments in schizo-obsessive disorder
Levent SEVİNÇOK
09:00 - 10:30
CONFERENCE 13
Chairperson/Moderator:
Nursu ÇAKIN MEMİK, Tayyib KADAK
Intersections of cultural formulation and psychotherapy in child and adolescent therapy
Jaswant GUZDER (Canada)
11:00 - 12:30
SYMPOSIA ORAL SESSION 30
How Can We Overcome Treatment Resistence in Schiophrenia? Is Clozapine Fear Justifiable or Exaggerated? Principles of Clozapine Treatment in Stages and Psychosocial Approaches in Overcoming Treatment Resistence
How Can We Overcome Treatment Resistence in Schiophrenia? Is Clozapine Fear Justifiable or Exaggerated? Principles of Clozapine Treatment in Stages and Psychosocial Approaches in Overcoming Treatment Resistence
Chairperson/Moderator:
Rüstem AŞKIN, Mesut ÇETİN (TAP)
Before starting clozapine
Hüseyin GÜLEÇ
While starting clozapine
Şakir GICA
After starting clozapine
Salime GÜRSOY
Psychotherapy and psychosocial treatments in scizophrenia
Köksal ALPTEKİN
13:30 - 15:00
SYMPOSIA ORAL SESSION 33
New Waves of Psychotherapies and Their Status in Turkey
New Waves of Psychotherapies and Their Status in Turkey
Chairperson/Moderator:
Kazım YAZICI (TAP)
What does psychodynamic psychotherapy promise us?
Serhat ÇITAK (TAP)
New waves of cognitive and behavioral therapy (CBT)
M. Hakan TÜRKÇAPAR (TAP)
What is the current status of psychotherapies in Turkey?
Erol GÖKA (TAP)
An integrative approach to psychotherapies
Kemal SAYAR (TAP)
15:30 - 17:00
SYMPOSIA ORAL SESSION 36
Theory of Mind and Its Applications in Children
Theory of Mind and Its Applications in Children
Chairperson/Moderator:
Özlem YILDIZ, Ayhan BİLGİÇ
Development and neurobiology of nheory of mind
Abdullah BOZKURT
Theory of mind in children and psychopathology
Berkan ŞAHİN
Mind-based treatments
Saliha BAYKAL
Theory of mind: division of the internal and external world
Koray KARABEKİROĞLU
17:30 - 19:00
SYMPOSIA ORAL SESSION 40
A Different View of Child Psychopharmacology
A Different View of Child Psychopharmacology
Chairperson/Moderator:
Tayyib KADAK, Ömer Faruk AKÇA
Do we use psychopharmacological agents in children appropriately or over-use them?
Dursun KARAMAN
Differences in psychopharmacology of pediatric bipolar disorder and adult bipolar disorder
Halil KARA
Differences in psychopharmacology of pediatric schizophrenia and adult schizophrenia
Özge DEMİRCAN TULACI
Mechanisms of molecular efficacy of psychostimulants in ADHD
Şahin BODUR
07:00 - 08:30
COURSE 21
Mother-infant interaction: a multiaxial assessment (ABEÇED)
Koray KARABEKİROĞLU
09:00 - 10:30
SYMPOSIA ORAL SESSION 28
New Technologies and Applications in Psychiatry
New Technologies and Applications in Psychiatry
Chairperson/Moderator:
Hasan Turan KARATEPE (TAP), Şengül İLKAY
Virtual reality (VR)
Şengül İLKAY
Telemedicine
Mehmet Emrah KARADERE
Optical coherence tomography (OCT)
Mehmet Hamdi ÖRÜM
Artificial intelligence and its psychiatric use
Ezgi İNCE GULIYEV
11:00 - 12:30
CONFERENCE 15
Chairperson/Moderator:
Bengi SEMERCİ (TAP), Umut Mert AKSOY (TAP)
Effects of stimulant treatment in adult ADHD: from symptom reduction to functional improvement
Wolfgang RETZ (Germany)
13:30 - 15:00
SYMPOSIA ORAL SESSION 34
Bipolar disorder with comorbid anxiety disorders
Bipolar disorder with comorbid anxiety disorders
Chairperson/Moderator:
Levent SEVİNÇOK, David OSSER (USA)
Prevalence of comorbid anxiety disorders in bipolar disorder
Merve YALÇINAY İNAN
Determinants of comorbid anxiety disorders in bipolar disorder
Anıl Şafak KAÇAR
Neurobiology and treatment of comorbid anxiety disorders in bipolar disorder
Hale YAPICI ESER
15:30 - 17:00
SYMPOSIA ORAL SESSION 37
Obsessive Compulsive Disorder in Children and Adolescents
Obsessive Compulsive Disorder in Children and Adolescents
Chairperson/Moderator:
Nursu ÇAKIN MEMİK, Fatih CEYLAN
Novel approaches in neurobiology of obsessive compulsive disorder: where is glutamate in the OCD brain?
İpek PERÇİNEL YAZICI
Can we identify Obsessive Compulsive Disorder adequately? Problems in diagnosis
İlknur UCUZ
Where do we stand on the pharmacological treatment of resistant Obsessive Compulsive Disorder? Novel alternatives
Kemal Utku YAZICI
Revisiting the Obsessive Compulsive Disorder from a psychotherapeutic framework
Özlem ÖZEL ÖZCAN
17:30 - 19:00
SYMPOSIA ORAL SESSION 41
Psychopharmacological Treatments in Autistic Spectrum Disorders (ASD)
Psychopharmacological Treatments in Autistic Spectrum Disorders (ASD)
Chairperson/Moderator:
Işık GÖRKER, Burak DOĞANGÜN
Use of antipsychotics in children and adolescents with ASD
Selma TURAL HESAPÇIOĞLU
Psychopharmacological treatment of attention-deficit/ hyperactivity disorder comorbidity in ASD
Gülser ŞENSES DİNÇ
Use of SSRIs and other psychotropics in ASD
Tülin FİDAN
Problematic sexual behaviors and their treatment in children and adolescents with ASD and intellectual disability
Mehmet Fatih CEYLAN
07:00 - 08:30
ORAL PRESENTATIONS 12
SS-103, SS-105, SS-106, SS-107, SS-108, SS-110, SS-112, SS-114, SS-115
SS-103, SS-105, SS-106, SS-107, SS-108, SS-110, SS-112, SS-114, SS-115
Chairperson/Moderator:
Murat ALTIN (TAP)
09:00 - 10:30
SYMPOSIA ORAL SESSION 29
Depression Treatment: Beyond Antidepressants Use?
Depression Treatment: Beyond Antidepressants Use?
Chairperson/Moderator:
Mustafa SOLMAZ (TAP), Servet EBRİNC (TAP)
Any beneficial affects of exercise on depression?
Ayşe SAKALLI KANİ
What are positive/negative affects of nutrition on depression?
Mesut YILDIZ (TAP)
Light therapies in depression treatment
Neşe YORGUNER KÜPELİ
Phytotherapy for depression
Serkut BULUT
11:00 - 12:30
SYMPOSIA ORAL SESSION 31
Resilience from All Aspects
Resilience from All Aspects
Chairperson/Moderator:
Yasemen IŞIK, Kemal Utku YAZICI
Child psychiatrist’s view of resilience
Özlem ÖZEL ÖZCAN
Biological aspects of resilience beyond genetics
Hale YAPICI ESER
How can we increase resilience in children and adolescents?
Didem ÖZTOP
Distinct psychopathologies and their relationships with domains of resilience
Ali Evren TUFAN (TAP)
13:30 - 15:00
SYMPOSIA ORAL SESSION 35
Recent Evidences in the Etiology of Autism and Attention-Deficit/ Hyperactivity Disorder: How Influential Are Environmental Factors in the Etiology and Treatment of ADHD?
Recent Evidences in the Etiology of Autism and Attention-Deficit/ Hyperactivity Disorder: How Influential Are Environmental Factors in the Etiology and Treatment of ADHD?
Chairperson/Moderator:
Ebru ÇENGEL KÜLTÜR, Esengül KAYAN
What does current literature tell us for the etiology of ADHD?
Umut Mert AKSOY (TAP)
What does current literature tell us for the etiology of autism?
Tayyib KADAK
Review of evidence-based approaches on environmental and other factors in ADHD and autism
M. Cem TARAKÇIOĞLU (TAP)
Can we develop different hypotheses for neurodevelopmental disorders?
Hasan ÖNAL
15:30 - 17:00
SYMPOSIA ORAL SESSION 38
Post-traumatic Stress Disorder and Appraches in Its Management
Post-traumatic Stress Disorder and Appraches in Its Management
Chairperson/Moderator:
Cem CERİT
Clinical manifestations of post-traumatic stress disorder
Feyza ÇELİK
Up-to-date psychopharmacological treatments in post-traumatic stress disorder
Esma AKPINAR ASLAN
Psychotherapies in post-traumatic stress disorder
Sedat BATMAZ
17:30 - 19:00
SYMPOSIA ORAL SESSION 42
Substance Use Disorders and Sleep Disturbances
Substance Use Disorders and Sleep Disturbances
Chairperson/Moderator:
Çiçek HOCAOĞLU, Servet EBRİNÇ (TAP)
Substance use disorders and sleep
Kader Semra KARATAŞ
Substance use disorders and phytotherapy
Bülent BAHÇECİ
Substance use disorders in children and adolescents and sleep disturbances
Murat KAÇAR
07:00 - 08:30
ORAL PRESENTATIONS 13
SS-116, SS-117, SS-120, SS-122, SS-123, SS-124, SS-128, SS-129, SS-130
SS-116, SS-117, SS-120, SS-122, SS-123, SS-124, SS-128, SS-129, SS-130
Chairperson/Moderator:
Ömer YANARTAŞ (TAP)
09:00 - 10:30
COURSE 23
How do we combine psychotherapy and psychopharmacology in treatment?
Hakan TÜRKÇAPAR
11:00 - 12:30
SYMPOSIA ORAL SESSION 32
Unique Approaches to Patients with Epilepsy and Collaboration in the Management
Unique Approaches to Patients with Epilepsy and Collaboration in the Management
Chairperson/Moderator:
Çiçek HOCAOĞLU, Esra YAZICI
Up-to-date commonly used medications in the treatment of epilepsy
Figen YAVLALI
Depression and anxiety Disorders in patients with epilepsy
Gamze ERGİL ALTIN (TAP)
Treatment of depression and anxiety disorders in patients with epilepsy
Murat ALTIN (TAP)
Treatment of drug addiction in patients with epilepsy
Burak TOPRAK
13:30 - 15:00
COURSE 24
Brain Gut Microbiota Axis: Psychobiotics and Mental Health
Brain Gut Microbiota Axis: Psychobiotics and Mental Health
Chairperson/Moderator:
Mesut YILDIZ (TAP), Murat ALTIN (TAP)
Gastrointestinal symptoms in mental disorders
Ali Emre ŞEVİK
A novel approach for understanding mental disorders: brain-gut axis
Serhat ERGUN (TAP)
Psychobiotics and their usage in mental disorders
Emel KURT
Microbiota: a novel therapeutic target for mental disorders
Ömer YANARTAŞ (TAP)
15:30 - 17:00
ORAL PRESENTATIONS 14
SS-038, SS-057, SS-064, SS-089, SS-127, SS-131, SS-137, SS-140
SS-038, SS-057, SS-064, SS-089, SS-127, SS-131, SS-137, SS-140
Chairperson/Moderator:
Murat ALTIN (TAP), Ömer YANARTAŞ (TAP)
17:30 - 19:00
SYMPOSIA ORAL SESSION 43
A Clinical Approach to Impulsivity
A Clinical Approach to Impulsivity
Chairperson/Moderator:
Levent SEVİNÇOK, Murat DEMET
Impulsivity in impulse control disorders and other psychiatric disorders
Murat ALTIN (TAP)
Impulsivity in children and adolescents
Esengül KAYAN
Impulsivity during pregnancy and postpartum period
Gamze ERGİL ALTIN (TAP)
09:00 - 10:30
SYMPOSIA ORAL SESSION 44
Up-to-date Psychopharmacological and Psychotherapy Managements in Substance Use Disorders
Up-to-date Psychopharmacological and Psychotherapy Managements in Substance Use Disorders
Chairperson/Moderator:
Ertuğrul KÖROĞLU
Up-to-date psychopharmacological approaches in substance use disorder treatment
Neslihan ALTUNSOY
Up-to-date psychosomatic approaches in substance use disorder treatment
İlker ÖZDEMİR
Cognitive behavioral therapy approaches in substance use disorder treatment
Erkan KURU
Comorbidity in substance use disorder and current treatment approaches
Gökçer TULACI